Status:
COMPLETED
Observational Study in Type 2 Diabetes Treated by an Intensive Insulin Treatment (ICT) Containing Once Daily Levemir® (Insulin Detemir)
Lead Sponsor:
Novo Nordisk A/S
Conditions:
Diabetes
Diabetes Mellitus, Type 2
Eligibility:
All Genders
18+ years
Brief Summary
This study is conducted in Europe. The aim of this observational study is to gain practical experience with once-daily Levemir administration in type 2 diabetes patients who were previously treated wi...
Eligibility Criteria
Inclusion
- Type 2 diabetic subjects on intensive insulin treatment (ICT)
- Eligibility for once daily insulin detemir administration
- Informed consent obtained before any observation-related activities
Exclusion
- Known or suspected allergy to insulin detemir
- Subjects previously enrolled in the observation
- Women who are pregnant, breast feeding or have the intention of becoming pregnant within 6 months.
Key Trial Info
Start Date :
March 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2009
Estimated Enrollment :
2289 Patients enrolled
Trial Details
Trial ID
NCT00657930
Start Date
March 1 2008
End Date
April 1 2009
Last Update
March 3 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Budapest, Hungary, 1025